Medical Writing. Joaquín Rodrigo, president of Biosim, has two main objectives for 2016 in the field of biosimilar medicines: "to be able to establish a specific and differentiated regulatory framework" on the one hand and "to support the dissemination and understanding of what these are products among the main parties involved, such as patients, doctors, pharmacists, health authorities, etc.”, on the other.